Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Zulresso: the world’s first post-partum depression drug

Sage Therapeutics’ Zulresso became the world’s first drug for post-partum depression when it was approved by the FDA in March this year. The company plans to use the success of Zulresso’s novel mechanism of action as a catalyst to capitalise on a growing market and further expand its post-partum depression portfolio. Allie Nawrat reports.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free


Go Top